1. Home
  2. WABC vs DMRA Comparison

WABC vs DMRA Comparison

Compare WABC & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

HOLD

Current Price

$60.32

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$28.56

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WABC
DMRA
Founded
1972
2011
Country
United States
United States
Employees
627
7
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
WABC
DMRA
Price
$60.32
$28.56
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$54.00
$43.00
AVG Volume (30 Days)
178.5K
466.5K
Earning Date
04-16-2026
05-11-2026
Dividend Yield
3.35%
N/A
EPS Growth
N/A
N/A
EPS
3.40
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.93
$16.50
52 Week High
$63.61
$34.89

Technical Indicators

Market Signals
Indicator
WABC
DMRA
Relative Strength Index (RSI) 55.33 51.33
Support Level $56.88 $22.71
Resistance Level $60.54 $34.89
Average True Range (ATR) 1.83 2.13
MACD -0.15 -0.44
Stochastic Oscillator 52.69 9.51

Price Performance

Historical Comparison
WABC
DMRA

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: